ELVN SG&A Expense Growth
Enliven Therapeutics Inc · SG&A Expense Growth
ELVN SG&A Expense Growth
Latest reported42.17%period ending
ELVN FY SG&A Growth (YoY) (0.00% → 42.17%)
Latest values, visible window
High-resolution chart · PNG
ELVN sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 42.1686% | |
| 25.4339% | |
| 143.9825% | |
| 81.18% | |
| 297.7737% | |
| -78.7544% | |
| 108.1214% | |
| 147.0111% | |
| 0% |